ChemBridge Corporation is a privately held, US company founded in Chicago in 1993 and relocated to San Diego in 1997. ChemBridge’s administration, sales & marketing and US operations and logistics are based at our San Diego, CA headquarters. Sales and business development is supported by representatives based in the United Kingdom and Switzerland and a distributor in Japan. ChemBridge operates a large, state-of-the-art offshore chemistry research and order fulfillment site in Moscow, Russia, with over 250 employees. Our team includes over 110 chemists with a high ratio of chemists holding Ph.D. and M.S. degrees. 

ChemBridge offers an extensive portfolio of advanced discovery chemistry products and contract research services. Our products include high quality screening libraries and proprietary building blocks. We have been a major supplier of non-exclusive druglike and like screening libraries since 1993, and over 400 pharmaceutical, biotech and academic organizations worldwide have taken advantage of the access to ChemBridge’s growing stock of more than 700,000 diverse and targeted small molecule compounds. Our libraries offer premium quality hand-crafted compounds or novel parallel-synthesized screening libraries with built-in SAR. Our high purity, medicinally relevant building blocks are listed in major third party databases and can also be searched directly at our Hit2Lead.com site.

Our Discovery Chemistry Services division is ChemBridge’s largest and fastest growing business division, and our Moscow research facility has a well-established track record of meeting and exceeding client requirements. ChemBridge offers medicinal chemistry support and synthesis of exclusive lead generation and hit to lead libraries. ChemBridge has publicly announced, multi-year chemistry service collaborations, as well as unannounced collaborations.

ChemBridge Corporation offers a broad portfolio of efficient and cost-effective enabling chemistry solutions for drug discovery organizations.